These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21060308)

  • 1. The cost of large numbers of hypothesis tests on power, effect size and sample size.
    Lazzeroni LC; Ray A
    Mol Psychiatry; 2012 Jan; 17(1):108-14. PubMed ID: 21060308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.
    Brookes ST; Whitley E; Peters TJ; Mulheran PA; Egger M; Davey Smith G
    Health Technol Assess; 2001; 5(33):1-56. PubMed ID: 11701102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Required sample size to detect mediation in 3-level implementation studies.
    Williams NJ; Preacher KJ; Allison PD; Mandell DS; Marcus SC
    Implement Sci; 2022 Oct; 17(1):66. PubMed ID: 36183090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of genome-wide power of genetic association studies based on empirical data from the HapMap project.
    Nannya Y; Taura K; Kurokawa M; Chiba S; Ogawa S
    Hum Mol Genet; 2007 Oct; 16(20):2494-505. PubMed ID: 17666406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinician's Guide to Understanding Effect Size, Alpha Level, Power, and Sample Size.
    Peterson SJ; Foley S
    Nutr Clin Pract; 2021 Jun; 36(3):598-605. PubMed ID: 33956359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance, Errors, Power, and Sample Size: The Blocking and Tackling of Statistics.
    Mascha EJ; Vetter TR
    Anesth Analg; 2018 Feb; 126(2):691-698. PubMed ID: 29346210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real world scenarios in rare variant association analysis: the impact of imbalance and sample size on the power in silico.
    Zhang X; Basile AO; Pendergrass SA; Ritchie MD
    BMC Bioinformatics; 2019 Jan; 20(1):46. PubMed ID: 30669967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal sample sizes for Welch's test under various allocation and cost considerations.
    Jan SL; Shieh G
    Behav Res Methods; 2011 Dec; 43(4):1014-22. PubMed ID: 21512873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On design considerations and randomization-based inference for community intervention trials.
    Gail MH; Mark SD; Carroll RJ; Green SB; Pee D
    Stat Med; 1996 Jun; 15(11):1069-92. PubMed ID: 8804140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing two variances for superiority/non-inferiority and equivalence: Using the exhaustion algorithm for sample size allocation with cost.
    Guo JH; Luh WM
    Br J Math Stat Psychol; 2020 May; 73(2):316-332. PubMed ID: 31190402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Power calculation for overall hypothesis testing with high-dimensional commensurate outcomes.
    Chi YY; Gribbin MJ; Johnson JL; Muller KE
    Stat Med; 2014 Feb; 33(5):812-27. PubMed ID: 24122945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical power of likelihood ratio and Wald tests in latent class models with covariates.
    Gudicha DW; Schmittmann VD; Vermunt JK
    Behav Res Methods; 2017 Oct; 49(5):1824-1837. PubMed ID: 28039681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
    Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Power and sample assessments for tests of hypotheses on cost-effectiveness ratios.
    Gardiner JC; Huebner M; Jetton J; Bradley CJ
    Health Econ; 2000 Apr; 9(3):227-34. PubMed ID: 10790701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Power and sample size calculations in the presence of phenotype errors for case/control genetic association studies.
    Edwards BJ; Haynes C; Levenstien MA; Finch SJ; Gordon D
    BMC Genet; 2005 Apr; 6():18. PubMed ID: 15819990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Planning sample sizes when effect sizes are uncertain: The power-calibrated effect size approach.
    McShane BB; Böckenholt U
    Psychol Methods; 2016 Mar; 21(1):47-60. PubMed ID: 26651984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exact Power and Sample Size Calculations for the Two One-Sided Tests of Equivalence.
    Shieh G
    PLoS One; 2016; 11(9):e0162093. PubMed ID: 27598468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focus on Data: Statistical Design of Experiments and Sample Size Selection Using Power Analysis.
    Ledolter J; Kardon RH
    Invest Ophthalmol Vis Sci; 2020 Jul; 61(8):11. PubMed ID: 32645134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A review of power and sample size estimation in genomewide association studies].
    Park AK; Kim H
    J Prev Med Public Health; 2007 Mar; 40(2):114-21. PubMed ID: 17426422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.